Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Ultrasound ; 26(2): 497-503, 2023 Jun.
Article in English | MEDLINE | ID: covidwho-20241318

ABSTRACT

AIM: To evaluate the role of lung ultrasound (LUS) in recognizing lung abnormalities in pregnant women affected by COVID-19 pneumonia. MATERIALS AND METHODS: An observational study analyzing LUS patterns in 60 consecutively enrolled pregnant women affected by COVID-19 infection was performed. LUS was performed by using a standardized protocol by Soldati et al. The scoring system of LUS findings ranged from 0 to 3 in increasing alteration severity. The highest score obtained from each landmark was reported and the sum of the 12 zones examined was calculated. RESULTS: Patients were divided into two groups: 26 (43.3%) patients with respiratory symptoms and 32 (53.3%) patients without respiratory symptoms; 2 patients were asymptomatic (3.3%). Among the patients with respiratory symptoms 3 (12.5%) had dyspnea that required a mild Oxygen therapy. A significant correlation was found between respiratory symptoms and LUS score (p < 0.001) and between gestational weeks and respiratory symptoms (p = 0.023). Regression analysis showed that age and respiratory symptoms were risk factors for highest LUS score (p < 0.005). DISCUSSION: LUS can affect the clinical decision course and can help in stratifying patients according to its findings. The lack of ionizing radiation and its repeatability makes it a reliable diagnostic tool in the management of pregnant women.


Subject(s)
COVID-19 , Humans , Female , Pregnancy , COVID-19/diagnostic imaging , SARS-CoV-2 , Pregnant Women , Lung/diagnostic imaging , Thorax , Ultrasonography/methods , COVID-19 Testing
2.
Sci Rep ; 13(1): 462, 2023 01 10.
Article in English | MEDLINE | ID: covidwho-2186084

ABSTRACT

The coronavirus is caused by the infection of the SARS-CoV-2 virus: it represents a complex and new condition, considering that until the end of December 2019 this virus was totally unknown to the international scientific community. The clinical management of patients with the coronavirus disease has undergone an evolution over the months, thanks to the increasing knowledge of the virus, symptoms and efficacy of the various therapies. Currently, however, there is no specific therapy for SARS-CoV-2 virus, know also as Coronavirus disease 19, and treatment is based on the symptoms of the patient taking into account the overall clinical picture. Furthermore, the test to identify whether a patient is affected by the virus is generally performed on sputum and the result is generally available within a few hours or days. Researches previously found that the biomedical imaging analysis is able to show signs of pneumonia. For this reason in this paper, with the aim of providing a fully automatic and faster diagnosis, we design and implement a method adopting deep learning for the novel coronavirus disease detection, starting from computed tomography medical images. The proposed approach is aimed to detect whether a computed tomography medical images is related to an healthy patient, to a patient with a pulmonary disease or to a patient affected with Coronavirus disease 19. In case the patient is marked by the proposed method as affected by the Coronavirus disease 19, the areas symptomatic of the Coronavirus disease 19 infection are automatically highlighted in the computed tomography medical images. We perform an experimental analysis to empirically demonstrate the effectiveness of the proposed approach, by considering medical images belonging from different institutions, with an average time for Coronavirus disease 19 detection of approximately 8.9 s and an accuracy equal to 0.95.


Subject(s)
COVID-19 , Deep Learning , Lung Diseases , Pneumonia , Humans , COVID-19/diagnosis , SARS-CoV-2
3.
Comput Methods Programs Biomed ; 220: 106824, 2022 Jun.
Article in English | MEDLINE | ID: covidwho-1797041

ABSTRACT

BACKGROUND AND OBJECTIVE: Artificial Intelligence has proven to be effective in radiomics. The main problem in using Artificial Intelligence is that researchers and practitioners are not able to know how the predictions are generated. This is currently an open issue because results' explainability is advantageous in understanding the reasoning behind the model, both for patients than for implementing a feedback mechanism for medical specialists using decision support systems. METHODS: Addressing transparency issues related to the Artificial Intelligence field, the innovative technique of Formal methods use a mathematical logic reasoning to produce an automatic, quick and reliable diagnosis. In this paper we analyze results given by the adoption of Formal methods for the diagnosis of the Coronavirus disease: specifically, we want to analyse and understand, in a more medical way, the meaning of some radiomic features to connect them with clinical or radiological evidences. RESULTS: In particular, the usage of Formal methods allows the authors to do statistical analysis on the feature value distributions, to do pattern recognition on disease models, to generalize the model of a disease and to reach high performances of results and interpretation of them. A further step for explainability can be accounted by the localization and selection of the most important slices in a multi-slice approach. CONCLUSIONS: In conclusion, we confirmed the clinical significance of some First order features as Skewness and Kurtosis. On the other hand, we suggest to decline the use of the Minimum feature because of its intrinsic connection with the Computational Tomography exam of the lung.


Subject(s)
Artificial Intelligence , Radiology , Humans , Tomography, X-Ray Computed
4.
Heliyon ; 7(5): e07112, 2021 May.
Article in English | MEDLINE | ID: covidwho-1240372

ABSTRACT

PURPOSE: To investigate the early CT findings in COVID-19 pneumonia as compared to influenza A virus H1N1 (AH1N1), with focus on vascular enlargement within consolidation or ground glass opacity (GGO) areas. METHODS: 50 patients with COVID-19 pneumonia were retrospectively compared to 50 patients with AH1N1 pneumonia diagnosed during the 2009 pandemic. Two radiologists reviewed chest CT scans independently and blindly, with discordance resolved by consensus. Dilated or tortuous vessels within hyperdense lesions were recorded. RESULTS: COVID-19 pneumonia presented with bilateral (96%), peripheral areas of GGO (22%), consolidation (4%) or combined GGO-consolidation (74%). The vascular enlargement sign in COVID-19 pneumonia was much more commonly present in COVID-19 (45/50, 90%) versus AH1N1 pneumonia (12/50, 24%) (p < 0.001). Vascular enlargement was more often present in lower lobes with a peripheral distribution. CONCLUSIONS: Vascular enlargement in consolidative/GGO areas may represent a reasonably common early CT marker in COVID-19 patients and is of uncertain etiology. Although speculative, theoretical mechanisms could potentially reflect acute inflammatory changes, pulmonary endothelial activation, or acute stasis. Further studies are necessary to verify specificity and to study if prognostic for clinical outcomes.

5.
Diagnostics (Basel) ; 11(2)2021 Feb 12.
Article in English | MEDLINE | ID: covidwho-1085112

ABSTRACT

Considering the current pandemic, caused by the spreading of the novel Coronavirus disease, there is the urgent need for methods to quickly and automatically diagnose infection. To assist pathologists and radiologists in the detection of the novel coronavirus, in this paper we propose a two-tiered method, based on formal methods (to the best of authors knowledge never previously introduced in this context), aimed to (i) detect whether the patient lungs are healthy or present a generic pulmonary infection; (ii) in the case of the previous tier, a generic pulmonary disease is detected to identify whether the patient under analysis is affected by the novel Coronavirus disease. The proposed approach relies on the extraction of radiomic features from medical images and on the generation of a formal model that can be automatically checked using the model checking technique. We perform an experimental analysis using a set of computed tomography medical images obtained by the authors, achieving an accuracy of higher than 81% in disease detection.

7.
Procedia Comput Sci ; 176: 2212-2221, 2020.
Article in English | MEDLINE | ID: covidwho-843271

ABSTRACT

At the end of 2019, a new form of Coronavirus, called COVID-19, has widely spread in the world. To quickly screen patients with the aim to detect this new form of pulmonary disease, in this paper we propose a method aimed to automatically detect the COVID-19 disease by analysing medical images. We exploit supervised machine learning techniques building a model considering a data-set freely available for research purposes of 85 chest X-rays. The experiment shows the effectiveness of the proposed method in the discrimination between the COVID-19 disease and other pulmonary diseases.

8.
Comput Methods Programs Biomed ; 196: 105608, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-610088

ABSTRACT

BACKGROUND AND OBJECTIVE: Coronavirus disease (COVID-19) is an infectious disease caused by a new virus never identified before in humans. This virus causes respiratory disease (for instance, flu) with symptoms such as cough, fever and, in severe cases, pneumonia. The test to detect the presence of this virus in humans is performed on sputum or blood samples and the outcome is generally available within a few hours or, at most, days. Analysing biomedical imaging the patient shows signs of pneumonia. In this paper, with the aim of providing a fully automatic and faster diagnosis, we propose the adoption of deep learning for COVID-19 detection from X-rays. METHOD: In particular, we propose an approach composed by three phases: the first one to detect if in a chest X-ray there is the presence of a pneumonia. The second one to discern between COVID-19 and pneumonia. The last step is aimed to localise the areas in the X-ray symptomatic of the COVID-19 presence. RESULTS AND CONCLUSION: Experimental analysis on 6,523 chest X-rays belonging to different institutions demonstrated the effectiveness of the proposed approach, with an average time for COVID-19 detection of approximately 2.5 seconds and an average accuracy equal to 0.97.


Subject(s)
Coronavirus Infections/diagnostic imaging , Deep Learning , Pneumonia, Viral/diagnostic imaging , Radiography, Thoracic/methods , Algorithms , Betacoronavirus , COVID-19 , Humans , Image Processing, Computer-Assisted/methods , Lung Diseases/diagnostic imaging , Neural Networks, Computer , Pandemics , Radiographic Image Interpretation, Computer-Assisted/methods , Reproducibility of Results , SARS-CoV-2 , X-Rays
9.
Radiol Med ; 125(8): 738-753, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-597679

ABSTRACT

Ultrasound is the most disruptive innovation in intensive care life, above all in this time, with a high diagnostic value when applied appropriately. In recent years, point-of-care lung ultrasound has gained significant popularity as a diagnostic tool in the acutely dyspnoeic patients. In the era of Sars-CoV-2 outbreak, lung ultrasound seems to be strongly adapting to the follow-up for lung involvement of patients with ascertaining infections, till to be used, in our opinion emblematically, as a screening test in suspected patients at the emergency triage or at home medical visit. In this brief review, we discuss the lung ultrasound dichotomy, certainties and uncertainties, describing its potential role in validated clinical contexts, as a clinical-dependent exam, its limits and pitfalls in a generic and off-label clinical context, as a virtual anatomical-dependent exam, and its effects on the clinical management of patients with COVID-19.


Subject(s)
Artifacts , Coronavirus Infections/diagnostic imaging , Pneumonia, Viral/diagnostic imaging , Ultrasonography/methods , Betacoronavirus , COVID-19 , Diagnosis, Differential , Humans , Pandemics , Point-of-Care Systems , SARS-CoV-2 , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL